[ad_1]
Amid multinational pharmaceutical companies announcing interim results related to the new vaccine against coronavirus infection (Corona 19), the government emphasized that there will be no problems with its plan to secure 30 million vaccines next year.
Script “Negotiating with leading companies”
Gang-tae, the first general coordinator of the Security and Disaster Countermeasures Headquarters (second deputy minister of the Ministry of Health and Welfare) said in a regular briefing on the 18th: “They are currently negotiating with leading companies that are achieving great achievements and there will be no major problems achieving the objectives. ”
Pfizer-Bioentech is developing a candidate vaccine. Reuters = Yonhap News
Vice Minister Kang said: “Recently, multinational pharmaceutical companies have announced positive interim results related to vaccine development, and this news will continue to be announced in the future.” “Expectations are growing around the world and more and more attention is being paid to Korea’s vaccine procurement plan. It is becoming “.
“The government has set a goal of supplying 30 million vaccines next year and has secured 10 million vaccines through the COVAX Facility (an international project for the joint purchase and distribution of vaccines). “We are in the negotiation process to secure the drug through various pharmaceutical companies.”
Earlier, Kwon Jun-wook, head of the second headquarters of the Centers for Disease Control and Prevention (National Institute for Health Research), said in a briefing on the 17th that “we are in the process of negotiating the purchase of 5 vaccine products that have entered clinical trials. ”
Corona vaccine. AFP = Yonhap News
Assistant CEO Kwon said: “Currently, there are about 10 vaccines that have entered phase 3 clinical trials. Except for the lack of data or information from clinical trials, about 5 are eligible to be purchased.” “Before vaccination against influenza (seasonal flu) in late fall next year We are pursuing with the goal of completing vaccination against Corona 19.”
Deputy CEO Kwon said: “We first selected the targets through COVAX and narrowed the priority targets between them as negotiations with individual pharmaceutical companies were to finalize.” Situation. “Regarding the status of the contracts with the US pharmaceutical companies ‘Modena’ and ‘Pfizer’, which recently announced positive intermediate results, he said that” bilateral negotiations are already underway. ”
According to foreign news sources, following Pfizer, Modenasa recently announced an interim result that the prevention rate for corona 19 vaccine candidates was 94.5%. However, it has been noted that it would be difficult to introduce as a pre-purchase agreement was not signed with Modena.
However, Vice Minister Kang said: “We will organize and announce detailed vaccine procurement plans on what vaccines will be obtained and how to obtain them in November as much as possible.”
However, “it is understandable that the expectation for the vaccine is rising, but vaccination of the vaccine can take a considerable amount of time to go through a number of processes, including not only the production of the vaccine, but also the preparation of the supply system, including safety verification “. Remember that it is time to focus on controlling Corona 19 through Junsu and quarantine management in daily life. ”
Reporter Hwang Soo-yeon [email protected]
[ad_2]
